RoboCT Receives FDA Approval for Several Rehabilitation and Robotics Products

2022-09-01 | Company News

Recently, a number of rehabilitation and robotic products of RoboCT have completed the medical device certification by the Food and Drug Administration (FDA), and started the international market expansion. The FDA-approved materials, devices and technologies can be used commercially in the United States and other countries. The approval of RoboCT series of rehabilitation robotic products by the FDA is an important milestone for the company's development, and also marks China's independent exoskeleton robot brand to the world.

The products approved by FDA cover a total of 9 intelligent rehabilitation devices and robots in 5 categories, including lower limb walking rehabilitation, lower limb joint rehabilitation, upper limb hand function rehabilitation, rehabilitation assistant robot, and intelligent physical therapy rehabilitation.

FDA approved

RoboCT completed the FDA medical device registration of the series products, that is, to get the "pass" for the U.S. market, laying the foundation of qualification for subsequent product exports. With the normalization of the epidemic, many governments around the world are aware of the importance of medical investment, and are facing greater financial pressure, so they are more sensitive to price, and RoboCT's advantages of self-research and self-production will be more and more prominent. Through this opportunity, RoboCT Technology will continue to try to promote its own equipment products to the international market, so that domestic technology rehabilitation more competitive, to provide better quality products and services for the rehabilitation population.

 

FDA

FDA is the abbreviation of Food and Drug Administration, which sometimes stands for United States Food and Drug Administration. It is also a government health control monitoring agency composed of professionals such as doctors, lawyers, microbiologists, chemists and statisticians who are dedicated to protecting, promoting and improving the health of the nation. Many other countries seek and receive help from the FDA to promote and monitor the safety of their products.

Back To The List

Related News

https://cdn.mysitefy.com/img/2022-09-20.13-40-18.22c9a4a99647ed3c356e8480656fd221.jpg

Witness the "New Decade of Exoskeleton" with RoboCT

Recently, the 6th Future Healthcar VB100 was held online, which invited innovators from various fields of healthcare industry to discuss and share the new development of China's healthcare industry through immersive online presentations and dialogues. RoboCT was invited to attend the conference and was selected as one of the TOP 100 innovative medical devices and won the Pharma Orange Award - Innovative Company of the Year.

View Details 2022-09-01
https://cdn.mysitefy.com/img/2022-09-20.11-40-50.a5d041cf1e43949d1729bcfa62cf5fa2.jpg

UGO Exoskeleton Won the IAI Intelligent Manufacture Award

The 2021/2022 IAI Global Design Award (Intelligent Manufacture Award) results are officially released, RoboCT UGO exoskeleton won the IAI Intelligent Manufacture Award with its innovative shape, simple design and functional value, and was honored on the cover of the award, showing the strength of China's industrial design and technological innovation to global consumers.

View Details 2022-09-01
https://cdn.mysitefy.com/img/2022-09-20.11-36-45.3b252b9df2f8ceaada5bda541e1eb7a5.png

Exhibition Update: RoboCT Attends the 2022 CIFTS

Leading digital intelligence health and wellness.

View Details 2022-09-01